Dopamine transporter gene expression in rat mesencephalic dopaminergic neurons is increased by direct interaction with target striatal cells in vitro

Molecular Brain Research

Volumn 39, Issue 1-2, 1996, Pages 160-166

  Perrone Capano, Carla ^a,b   Tino, Angela ^b   Amadoro, Giuseppina ^b   Pernas Alonso, Roberto ^b   Di Porzio, Umberto ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

Dopamine; Neuronal interaction; Reverse transcriptase PCR; Synaptic vesicle monoamine transporter; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; EMBRYO DEVELOPMENT; FEMALE; FETUS; GENE EXPRESSION; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPSE VESICLE;

ANIMALIA;

EID: 0029952149     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(96)00022-8     Document Type: Article

References (40)

1. Amara, S.G. and Arriza, J.L., Neurotransmitter transporters: three distinct gene families, Curr. Opin. Neurobiol., 3 (1993) 337-344.
2. Bannon, M.J., Poosch, M.S., Xia, Y., Goebel, D.J., Cassin, B. and Kapatos, G., Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age, Proc. Natl. Acad. Sci. USA, 89 (1992) 7095-7099.
3. Bankievitz, K.S., Plunkett, R.J., Jacobowitz, D.M., Porrino, L., di Porzio, U., London, W.T., Kopin, I.J. and Oldfield, E.H., The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism, J. Neurosurg., 72 (1990) 231-244.
4. Cerruti, C., Pilotte, N.S., Uhl, G. and Kuhar, M.J., Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration, Mol. Brain Res., 22 (1994) 132-138.
5. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162 (1987) 156-159.
6. Daguet, M.C., di Porzio, U., Prochiantz, A., Kato A. and Glowinski, J., Release of dopamine from dissociated mesencephalic neurons in primary cultures in absence or presence of striatal target cells, Brain Res. 191 (1980) 564-568.
7. Di Porzio, U., Daguet, M.C., Glowinski, J. and Prochiantz, A., Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurons grown in serum-free conditions, Nature, 288 (1980) 370-373.
8. Di Porzio, U, Zuddas, A., Cosenza-Murphy, D.B. and Barker, J.L., Early appearance of tyrosine hydroxylase immunoreactive neurons in the mesencephalon of mouse embryos, Intern. J. Dev. Neurosci., 8 (1990) 523-532.
9. Edwards, R.H., The transport of neurotransmitters into synaptic vesicles. Curr. Opin. Neurobiol., 2 (1992) 586-594.
10. Erickson, J.D., Eiden, L.E. and Hoffman, B.J., Expression cloning of a reserpine-sensitive vesicular monoamine transporter, Proc. Natl. Acad. Sci. USA, 89 (1992) 10993-10997.
11. Fiszman, M.L., Zuddas, A., Masana, M.I., Barker, J.L. and di Porzio, U., Dopamine synthesis precedes dopamine uptake in embryonic rat mesencephalic neurons, J. Neurochem., 56 (1991) 392-399.
12. Giros, B., El Mestikawy, S., Bertrand, L. and Caron, L.G., Cloning and functional characterization of a cocaine-sensitive dopamine transporter, FEBS Lett., 295 (1991) 149-154.
13. Grima, B., Lamouroux, A., Blanot, F., Biguet N.F. and Mallet, J., Complete coding sequence of rat tyrosine hydroxylase mRNA, Proc. Natl. Acad. Sci. USA, 82 (1985) 617-621.
14. Hyman, C., Juhasz, M., Jackson, C., Wright, P., Ip, N.Y. and Lindsay, R., Overlapping and distinct actions of the neurotrophins BDNF, NT-3 and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon, J. Neurosci., 14 (1994) 335-347.
15. Horn, A.S., Dopamine uptake: a review of progress in the last decade, Prog. Neurobiol., 34 (1990) 387-400.
16. Hynes, M.A., Poulsen, K., Armanini, M., Berkemeier, L., Phillips H. and Rosenthal, A., Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures, J. Neurosci. Res., 37 (1994) 144-154.
17. Javitch, J.A., D'Amato, R.J., Strittmatter, S.M. and Snyder, S.H., Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetra-hydro pyridine: uptake of the metabolite N-methyl-4-phenyl-pyridine by dopamine neurons explains selective toxicity, Proc. Natl. Acad. Sci. USA, 82 (1985) 2173-2177.
18. Jenner, P., Schapira, A.H. and Marsden, C.D., New insights into the cause of Parkinson's disease, Neurology, 42 (1992) 2241-2250.
19. Kilty, J.E., Lorang, D. and Amara, S.G., Cloning and expression of a cocaine-sensitive rat dopamine transporter, Science, 254 (1991) 578-579.
20. + toxicity encodes a vesicular amine transporter, Cell, 70 (1992) 539-551.
21. Lin, L.H., Doherti, D.H., Lile, J.D., Becktesh, S. and Collins, F., GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science, 260 (1993) 1130-1132.
22. Lorang, D., Amara, S.G. and Simerly, R.B., Cell-type-specific expression of catecholamine transporters in the rat brain, J. Neurosci., 14 (1994) 4903-4914.
23. Malmberg, A., Jackson, D.M., Erickson, A. and Mohell, N., Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors, Mol. Pharmacol., 43 (1993) 749-754.
24. Nagata, K., Takei, N., Nakajima, K., Saito, H. and Kohsaka, S., Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain, J. Neurosci. Res., 34 (1993) 357-363.
25. Nijma, K., Araki, M., Ogawa, M., Nagatsu, I., Sato, F., Kimura, H. and Yoshida, M., Enhanced survival of cultured dopamine neurons by treatment with soluble extracts from chemically deafferentiated striatum of adult brain, Brain Res., 528 (1990) 151-154.
26. Perrone-Capano, C., Tino, A. and di Porzio, U., Target cells modulate dopamine transporter gene expression during brain development, NeuroReport, 5 (1994) 1145-1148.
27. Poulsen, K.T., Armanini, M.P., Klein, R.D., Hynes, M.A., Phillips, H.S. and Rosenthal, A., TGFβ2 and TGFβ3 are potent survival factors for midbrain dopaminergic neurons, Neuron, 13 (1994) 1245-1252.
28. Prochiantz, A., di Porzio, U., Kato, A., Berger, B. and Glowinski, J., In vitro maturation of mesencephalic dopaminergic neurons from mouse embryos is enhanced in presence of their striatal target cells, Proc. Natl. Acad. Sci. USA, 76 (1979) 5387-5391.
29. Ritz, M.C., Lamb, R.J., Goldberg, S.R. and Kuhar, M.J., Cocaine receptors on dopamine transporters are related to self-administration of cocaine, Science, 237 (1987) 1219-1223.
30. Shimada, S. Kitayama, S., Lin, C., Patel, A., Nanthakumar, E., Gregor, P., Kuhar, M. and Uhl, G., Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA, Science, 254 (1991) 576-578.
31. Schuldiner, S., A molecular glimpse of vesicular monoamine transporters, J. Neurochem., 62 (1994) 2067-2078.
32. Solberg, Y., Silverman, W.F. and Pollack, Y., Prenatal ontogeny of tyrosine hydroxylase gene expression in the rat ventral mesencephalon, Dev. Brain Res., 73 (1993) 91-97.
33. Steel, M. and Buckley, N.J., Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: a comparative polymerase chain reaction study, Mol. Pharmacol., 43 (1993) 694-701.
34. Tomozawa, Y. and Appel, S.H., Soluble striatal extracts enhance development of mesencephalic dopaminergic neurons in vitro, Brain Res., 399 (1986) 111-124.
35. Usdin, T.B., Eiden, L.E., Bonner, T.I. and Erickson, J.D., Molecular biology of the vesicular ACh transporter, Trends Neurosci., 18 (1995) 218-224.
36. Van Tol, H.H., Bunzow, J.R., Guan, H. G, Sunahara, R.K., Seeman, P., Niznick, H.B. and Civelli, O., Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine, Nature, 350 (1991) 610-614.
37. Willoughby, J., Cowburn, R.F., Hardy, J.A., Glover, V. and Sandler, M., 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes, J. Neurochem., 52 (1989) 627-631.
38. Xia, Y., Goebel, D.J., Kapatos, G. and Bannon, M.J., Quantitation of rat dopamine transporter mRNA: effects of cocaine treatment and withdrawal, J. Neurochem., 59 (1992) 1179-1182.
39. Zhou, Q.Y., Quaife, C.J. and Palmiter, R.D., Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development, Nature, 374 (1995) 640-643.
40. Zuddas, A., Corsini, G.U., Kopin, I.J., Barker, J.L. and di Porzio, U., Specific reinnervation of acetaldehyde/MPTP lesioned mouse striatum by grafted mesencephalic dopaminergic neurons, Eur. J. Neurosci., 3 (1991) 72-85.